Gene delivery into the glomerulus via mesangial cell vectors

Experimental Nephrology

Volumn 5, Issue 2, 1997, Pages 118-125

  Kitamura, Masanori ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

galactosidase; CarG box element; ex vivo gene transfer; gene therapy; glomerulus; kidney; mesangial cells; tetracycline responsive promoter

Indexed keywords

BETA GALACTOSIDASE;

ANIMAL CELL; CELL CULTURE; GENE THERAPY; GENE TRANSFER; GLOMERULUS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; BETA-GALACTOSIDASE; GENE EXPRESSION REGULATION; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GLOMERULAR MESANGIUM; HUMANS; KIDNEY GLOMERULUS; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0030887638     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Kitamura M: Transfer of exogenous genes into the kidney. Exp Nephrol 1994;2:313-317.
2. Kitamura M, Fine LG: Somatic gene transfer into the kidney: Current concepts and future prospects; in D'Amico G, Colasanti G (eds): Issues in Nephrosciences, Molecular Biology and Glomerulonephritis. Milan, Wichtig, 1995, vol 5/94, pp 37-45.
3. Kitamura M, Fine LG: Genetic manipulation of the kidney. Pediatr Nephrol 1996, in press.
4. Lien YH, Lai L, Moeckel GW, Xu H, Martin D, Erickson RP: Liposome-mediated gene transfer targeted to the kidney in mice: Comparison among intra-renal-arterial, retrograde intrapelvic, and intra-renal-parenchymal injection (abstract). J Am Soc Nephrol 1994;5:629.
5. Moullier P, Friedlander G, Calise D, Ronco P, Perricaudet M, Ferry N: Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int 1994;45:1220-1225.
6. Tomita N, Higaki J, Morishita R, Kato K, Mikami H, Kaneda Y, Ogihara T: Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun 1992;186:129-134.
7. Kitamura M, Taylor S, Unwin R, Burton S, Shimizu F, Fine LG: Gene transfer into the rat renal glomerulus via a mesangial cell vector: Site-specific delivery, in situ amplification and sustained expression of an exogenous gene in vivo. J Clin Invest 1994;94:497-505.
8. Larrick JW, Burck KL: Gene Therapy: Application of Molecular Biology. New York, Elsevier, 1991, pp 105-160.
9. Kitamura M, Shirasawa T, Maruyama N: Gene transfer of metalloproteinase transin induces aberrant behavior of cultured mesangial cells. Kidney Int 1994;45:1580-1586.
10. Remuzzi A, Brenner BM, Pata V, Tebaldi G, Mariano R, Belloro A, Remuzzi G: Three-dimensional reconstructed glomerular capillary network: Blood flow distribution and local filtration. Am J Physiol 1992;263:F562-F572.
11. Kitamura M, Burton S, Yokoo T, Fine LG: Gene delivery into the renal glomerulus by transfer of genetically engineered, autologous mesangial cells. Exp Nephrol 1996;4:56-59.
12. 1 suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int 1995;48:1747-1757.
13. Yokoo T, Kitamura M: Gene transfer of interleukin-1 receptor antagonist into the renal glomerulus via a mesangial cell vector. Biochem Biophys Res Commun 1996;226:883-888.
14. Kitamura M: Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus. Proc Natl Acad Sci USA 1996;93:7387-7391.
15. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoter. Proc Natl Acad Sci USA 1992;89:5547-5551.
16. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of 'muscle-specific' actin in glomerulonephritis. Kidney Int 1992; 41:1134-1142.
17. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE: The activated mesangial cell: A glomerular 'myofibroblast'? J Am Soc Nephrol 1992;2(suppl):190-197.
18. MacPherson BR, Leslie KO, Lizaso KV, Schwarz JE: Contractile cells of the kidney in primary glomerular disorders: An immunohistochemical study using an anti-alpha smooth muscle actin monoclonal antibody. Hum Pathol 1993;24:710-716.
19. Simonson MS, Walsh K, Kumar CC, Bushel P, Herman WH: Two proximal CArG elements regulate SM α-actin promoter. A genetic marker of activated phenotype of mesangial cells. Am J Physiol 1995;268:F760-F769.
20. 6GG elements (abstract). J Am Soc Nephrol 1996;7: 1757.
21. Kitamura M, Kawachi H: Creation of a cytosensor system by genetically engineered mesangial cells: Automatic sensing of glomerular inflammation and subsequent control of transgene activity (abstract). J Am Soc Nephrol 1996;7:1600.
22. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92: 2597-2601.
23. Gossen M, Bonin AL, Bujard H: Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem Sci 1993;18:471-475.
24. Gossen M, Freundlieb S, Bander G, Muller G, Hillen W, Bujard H: Transcriptional activation by tetracyclines in mammalian cells. Science 1995;268:1766-1769.
25. Delort JP, Capecchi MR: TAXI/UAS: A molecular switch to control expression of genes in vivo. Hum Gene Ther 1996;7:809-820.
26. Kitamura M, Sütö TS: Transfer of genetically engineered macrophages into the glomerulus. Kidney Int 1997, in press.
27. 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J Immunol 1996;156:2964-2971.
28. 1. Ann Surg 1994;220:508-519.
29. 1 reduces macrophage adhesiveness with consequent deactivation. Kidney Int 1996;50:445-452.
30. 1 (abstract). J Am Soc Nephrol 1996;7:1666.
31. Kitamura M: Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as transforming growth factor-β1. J Immunol 1997, in press.
32. Kitamura M, Sütö TS: TGF-β and glomerulonephritis: Anti-inflammatory versus prosclerotic actions. Nephrol Dial Transpl 1997, in press.
33. McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin MJ, Logan JS, Platt JL: Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1995;1:423-427.
34. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 1995;377: 630-632.
35. Palmer TD, Rosman GJ, Osborne WRA, Miller AD: Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced gene. Proc Natl Acad Sci USA 1991;88:1330-1334.
36. Challita P-M, Kohn DB: Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 1994;91:2567-2571.
37. Yokoo T, Kitamura M: Dual regulation of IL-1β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1. Am J Physiol 1996;270:F123-F130.
38. Yokoo T, Kitamura M: Antioxidant PDTC induces stromelysin expression in mesangial cells via a tyrosine kinase-AP-1 pathway. Am J Physiol 1996;270:F806-F811.
39. Yokoo T, Kitamura M: Opposite, binary regulatory pathways involved in IL-1-mediated stromelysin gene expression in rat mesangial cells. Kidney Int 1996;50:894-901.
40. Kitamura M, Yokoo T: Mesangial cell vector system: Efficient and site-specific gene transfer into the renal glomerulus using cultured glomerular cells. Kidney Dial 1995;38:527-532.